| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/22/2001 | WO2001019868A1 A novel angiogenesis inhibitor |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | WO2001019824A2 New active marine alkaloids |
| 03/22/2001 | WO2001019823A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
| 03/22/2001 | WO2001019800A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | WO2001019770A2 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | WO2001019542A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | WO2001019391A1 Topical treatment of streptococcal infections |
| 03/22/2001 | WO2001019377A1 Oenothein medicaments |
| 03/22/2001 | WO2001019367A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 03/22/2001 | WO2001019353A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | WO2001019341A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | WO2001019323A1 Tyrosinase activity inhibitors and cosmetics |
| 03/22/2001 | WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | WO2001019191A1 Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2001019161A2 ANTISENSE MODULATION OF TRANSFORMING GROWTH FACTOR-β EXPRESSION |
| 03/22/2001 | WO2000078341A8 A method for the prophylaxis and/or treatment of medical disorders |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000059943A3 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000040576A3 Thiopyran compounds as inhibitors of mmp |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | DE19944464A1 Verfahren zur Herstellung von Polyvinylpyrrolidon-lod in wässriger Lösung A process for preparing polyvinylpyrrolidone-iodine in aqueous solution |
| 03/22/2001 | DE19944404A1 Mittel zur Therapie von menschlichen Erkrankungen, insbesondere für die Therapie von Tumoren wie Kolonkarzinomen und Melanomen oder zur Geweberegeneration und Förderung des Haarwuchses Means for therapy of human disease, in particular for the treatment of tumors such as colon carcinoma and melanoma, or for tissue regeneration and promote hair growth |
| 03/22/2001 | DE19944137A1 O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin O / W emulsions with a content of one or more bioquinones and an elevated content of glycerol |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2388383A1 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | CA2386525A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384782A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384656A1 New active marine alkaloids |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383565A1 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | CA2383402A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | CA2383038A1 Topical treatment of streptococcal infections |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | CA2381006A1 Antisense modulation of transforming growth factor-.beta. expression |
| 03/21/2001 | EP1084711A1 Remedies for itching containing pgd 2? antagonists |
| 03/21/2001 | EP1084708A1 A process of powder for bath from natural plants |
| 03/21/2001 | EP1084701A1 O/W-emulsion comprising one or several bioquinones and an elevated amount of glycerine |
| 03/21/2001 | EP1084695A1 Cosmetic composition containing at least a silicone/acrylate copolymer and at least a thickening agent |
| 03/21/2001 | EP1084114A1 Isothiazole derivatives useful as anticancer agents |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1084107A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 03/21/2001 | EP1084106A1 N-linked sulfonamides of heterocyclic carboxylic acids or carboxylic acid isosteres |
| 03/21/2001 | EP1084104A1 Nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083929A2 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 03/21/2001 | EP1083928A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | EP1083903A1 Bridged indenopyrrolocarbazoles |
| 03/21/2001 | EP1083900A2 Topical administration of oxazolidinones for transdermal delivery |
| 03/21/2001 | EP1083898A1 Novel use of hiv protease inhibiting compounds |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP1083886A1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 03/21/2001 | EP1083877A1 N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses |
| 03/21/2001 | EP1083876A1 Small molecule sulfonamide hair growth compositions and uses |
| 03/21/2001 | EP1083875A1 Small molecule carbamate or urea hair growth compositions and uses |
| 03/21/2001 | EP1083874A1 Small molecule pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | EP1083873A1 Heterocyclic thioester and ketone hair growth compositions and uses |
| 03/21/2001 | EP1083872A1 Pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | EP1083856A1 Topical transdermal treatments |
| 03/21/2001 | EP0714284B1 Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288380A Utilization of powder prepns. contg. hydroxypyridones treating LEG ulcer and decubitus ulcers |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1287855A Skin cleaning herb paste |
| 03/21/2001 | CN1287832A 樟脑搽剂 Camphor liniment |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/21/2001 | CN1063333C Liniment and its prepn. method |
| 03/21/2001 | CN1063325C Oral patent chinese medicine for treating psoriasis |
| 03/21/2001 | CN1063323C Mehtod for treatment of psoriasis |
| 03/21/2001 | CN1063311C Stable microemulsions of Certain 3-isothiazolone compounds |
| 03/21/2001 | CA2319842A1 Use of alverine to reduce wrinkles |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204295 Halogenated triphenylethylene derivatives,protection of human organs, from oxidative damage induced by lipid peroxidation and inhibiting the production of reactive oxygen species by activated neutrophils |
| 03/20/2001 | US6204294 IL-8 receptor antagonists |
| 03/20/2001 | US6204273 Treatment of androgenic sensitive disorders such as acne vulgaris, seborrhea, female hirsutism, male pattern baldness, and benign prostatic hyperplasia. |
| 03/20/2001 | US6204272 Considerable improvement in wound healing. |
| 03/20/2001 | US6204258 Enhancing hair growth or treating alopecia in a subject uses topically administered estrogen receptor antagonists. |